Lymphoma - Clinical Research

  • Visiting address

    Sweden

Unit profile

The area of research for our group is malignant lymphomas – aiming for the improvement of the quality of life and survival of these patients. The paradigm behind most of current health care is evidence –based medicine. The evidence basis is primarily derived from clinical trials, but data can also be extracted from alternate sources such as national or regional data registries. The objective of our research is to expand this evidence basis, currently through three strategies: 1. The development of cIinical trials - we have been involved in all stages of trials for lymphoma, and designed, conducted and initiated several. 2. Clinical epidemiology – using data from the Swedish Lymphoma Registry to provide clinically useful real world data on treatment and prognosis, in many cases in collaboration with Nordic colleagues. 3. Translational research – to identify predictive biomarkers for treatment decision – by immunohistochemistry, gene expression or sequencing.

UKÄ subject classification

  • Cancer and Oncology

Keywords

  • Lymphoma

Network

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
  • World Cancer Day 2020

    Susanne Dieroff Hay (Member of programme committee), Björn Ohlsson (Member of programme committee), Lisa Rydén (Member of programme committee), Mats Jerkeman (Member of programme committee), Karin Leandersson (Member of programme committee), Leena Liljedahl (Member of programme committee), Pia Berntsson (Member of programme committee), Kristian Pietras (Speaker), Lisa Ryden (Speaker), Björn ohlsson (Speaker), Mats Jerkeman (Speaker), Ulf Malmqvist (Speaker), Pia Dellson (Speaker) & Maria Bjerstam (Speaker)

    2020 Feb 4

    Activity: Participating in or organising an eventOrganisation of conference

    File